Services on Demand
Print version ISSN 0365-0596On-line version ISSN 1806-4841
An. Bras. Dermatol. vol.79 no.2 Rio de Janeiro Mar./Apr. 2004
Necrotizing Fasciitis: new insights with a focus on dermatological aspects*
Izelda Maria Carvalho CostaI; Andrea Leão Santos Veiga CabralII; Simone Saraiva de PontesII; Janaina Figueiredo de AmorimII
Degree in Dermatology, UFMG, Ph.D. in Dermatology, UNIFESP. Dermatologist, Hospital
Universitário - UnB and Professor, Research Supervisor, University of
Brasilia Post-Graduate program in Health Sciences (UNB)
IIEx-resident at the "Serviço de Dermatologia do Hospital Universitário - UnB"
Necrotizing fasciitis is a destructive and quickly progressing bacterial infection of the subcutaneous layer and superficial fascia. It is associated with high levels of unhealthiness and mortality if not treated early. Recently, countless published cases demonstrated an increasing frequency and severity of these infections, especially those caused by Group A Streptococcus (GAS), which afflicts even young and healthy persons. It is classified as type I when caused by a mixed anaerobic flora and other bacteria, and type II when caused by GAS alone or in association with Staphylococcus aureus. Predisposing factors include: chronic and malignant diseases, alcohol abuse, intravenous drug use, skin lesions such as chicken pox, chronic ulcers, psoriasis, surgery, and opened or closed traumas, among others. Clinical features are intense pain, severe edema, fast progress and poor antibiotic therapy feedback. A high level of suspicion is necessary to achieve a clinical diagnosis for this disease. Moreover, it is confirmed primarily when surgery takes place and reveals the superficial fascia necrosis. Radiological examinations are useful and the differential diagnosis must be done mainly with cellulitis at its initial stage. Treatment must be done early and with broad spectrum antibiotics, aggressive surgical debridement and clinical and nutritional support measures.
Key-words: fasciitis, necrotizing; fasciitis, necrotizing/diagnosis; fasciitis, necrotizing/therapy.
Necrotizing fasciitis (NF) is a destructive and quickly progressing bacterial infection of the subcutaneous tissue and superficial fascia, associated with high levels of morbidity and mortality.1,2
NF has also been referred to as hemolytic streptococcal gangrene, Meleney's ulcer, acute dermal gangrene, hospital gangrene, suppurative fasciitis and necrotizing synergistic cellulitis.
Fournier's gangrene is a form of NF afflicting the scrotal sac and perineal region. In its initial stage, NF may present with a more superficial infection of the soft skin, such as cellulitis and erysipela, and with other similarities regarding etiology and predisposing factors. Due to its high frequency, relative diagnostic ease and good response to treatment in these more superficial infections, therapeutic failures may be brought on in cases where there is progression with superficial fascia and subcutaneous affection with a high potential for severe complications.
As such, a high index of clinical suspicion is indispensable for early diagnosis and treatment of NF, which may reduce morbidity and mortality rates.
Clinical observation at the Service where the authors work and diverse reports found in the international literature show an increasing frequency and severity of soft tissue infections, mainly in immunosuppressive individuals. This is the case either for a basic disease or for other conditions, but also for those afflicting otherwise healthy individuals. It is also what has led the authors of the present paper to the carry out an extensive review of the literature on this theme so as to highlight the most interesting aspects as far as the dermatologist is concerned.
The clinical syndrome currently known as NF was first described at the end of the 18th century. It was one of the most terrible and fatal diseases to afflict soldiers.
In the 19th century, the pathology was known as malignant ulcer, phagedena and, eventually, hospital gangrene.
In the USA, the first cases of hospital gangrene were described during the Civil War. At the time, the only treatment available was amputation of the afflicted extremity. This procedure had a global mortality rate of 45%.
In 1924, Meleney described an ulcerous, progressive disease called "acute hemolytic streptococcal gangrene", which was intensely painful and produced by a synergistic association of streptococcus and staphylococcus. This entity presented a roughly 20% mortality rate and was finally called "necrotizing fasciitis".2
Group A streptococcus (GAS) is one of the pathogens to have significantly influenced the history of mankind. The scarlet fever epidemic, with a mortality rate of over 30% in children, marked the history of medicine. Wound infections by GAS, in either soldiers or civilians, and puerperal sepsis were the most dreaded infections in the age before antibiotics.4
In the 20th century, the proportion of severe infections caused by Group A Streptococcus showed a sharp decline. This may be easily attributed to improved living conditions and, later, to the development of antibiotics. However, the virulence of the agent seems to have diminished independently.4
Group A hemolytic streptococcus and staphylococcus aureus, alone or in synergy, are increasingly the initiating agents of NF.
They are surely not as common as the earlier form of NF caused by Clostridium perfringens. In a study dating from 1990, this latter agent was still only isolated in a percentage varying from 5 to 15 % of patients.
Nonetheless, other aerobic and anaerobic pathogens may be present, including Bacteroides, Clostridium, Peptostreptococcus, Enterobacteriaceae, coliforms, Proteus, Pseudomonas and Klebsiella. Bacteroides fragilis is usually found as part of a mixed flora in combination with Escherichia coli. They do not directly cause the infection, but may contribute to reducing interferon production and the phagocyte capacity of macrophages and polymorphonuclei.
In the 1980s and beginning of the 1990s, a large number of articles in the medical literature suggested that there was a resurgence of severe Group A Streptococcus infections. As far as what can be determined, it seems that this was exaggerated and sensationalistic, which contributed to coining the term "flesh-eating bacteria".3 Such infections are not uniformly described. The statistics are far from being definitive, with reports often being anecdotal.
Some authors still speculate about the possible emergence of a new clinical syndrome in adults, namely necrotizing fasciitis resulting from Group B Streptococcus. They suggested that the latter would have recently acquired an increasing ability to cause such infections.5
In fact, most authors are careful and refer to an "apparent" increase of these infections.4 The most convincing report on the increasingly severe infections by GAS was drafted by Martin and Hoiby from Norway in 1987 and 1988. Their report includes often severe cases of bacteremia with a 25% mortality rate, which affects young and healthy persons.6
Kaul and collaborators carried out a prospective study of 77 cases of streptococcus necrotizing fasciitis in Ontario between 1991 and 1995. The incidence increased from 0.085 per 100,000 inhabitants in the first year of the study to 0.40 per 100,000 by the second.2 The CDC estimates that 500 to 1,500 cases of necrotizing fasciitis occur in the USA yearly.7
NF is classified into types I and II (Chart). Type I or necrotizing cellulitis is characterized by isolation of at least one species of an obligatory anaerobic, such as Bacterioides and Peptostreptococcus, in combination with one or more optional anaerobic organism(s), like Enterobacter and streptococci not belonging to Group A.3 Type I most commonly occurs following surgery and in patients with diabetes and peripheral vascular disease.1
Type II or streptococcus gangrene is characterized by the isolation of Group A Streptococcus, either alone or in association with Staphylococcus aureus. It typically occurs after penetrating injuries, surgical procedures, burns and traumas, including even the mildest varieties. However, the previous trauma history may not be present in all cases.1
Various superficial components of Streptococcus pyogenes are involved in their ability to adhere and invade, such as M-protein and capsular protein. Streptococcal O and other bacterial products, such as pyrogenic exotoxins, are involved in tissue damage and necrosis. Toxins A and C act like superantigens and are expressed by cepas in association with toxic shock syndrome.
Regarding Staphylococcus aureus, the main pathogenic factors are the capsule, A protein and the toxin from staphylococcal toxic shock syndrome.
In NF, as well as in streptococcal toxic shock syndrome (STSS), superantigen reactions occur with the activation of over 10% CD4+ lymphocytes and the release of a large amount of cytokines.
Streptococcal products known as superantigen reaction triggers are the pyrogenic exotoxins, SPE A, SPE B and SPE C and M-protein.8 Superantigens like pyrogenic exotoxin A interact with monocytes and T-lymphocytes, resulting in the proliferation of T cells, production of monokines (TNF-alpha, interleukin 1, interleukin 6) and lymphokines (TNFb, interleukin 2 and interferon-gamma).9
Predisposing factors include the following conditions: chronic diseases (cardiac diseases, peripheral vascular disease, pulmonary diseases, renal insufficiency and diabetes mellitus), alcohol abuse, immunosuppressive conditions (use of systemic corticosteroids, collagen diseases, HIV infection, solid organ transplants and malignant diseases in treatment), the use of endovenous drugs, surgeries, chicken pox in children, ischemic and decubitus ulcers, psoriasis, contact with persons infected with Streptococcus and with penetrating, closed or even minimal cutaneous traumas.2,10-14
In 71% of the 77 cases he analyzed, Kaul R found at least one basic associated chronic disease.2 In a study of 68 cases, Bilton and collaborators found similar data (73%).16
More recently, many cases reported in the literature suggest an association of NF with the use of nonsteroidal anti-inflammatories. Among the hypotheses one may find induced depression of the lymphocyte function as well as lymphopenia contributing to sepsis in patients suffering from only small traumas.16 Another hypothesis is the simple masking of signs and symptoms of a pre-existing infection, which contributes to delaying the diagnosis.
Some authors speculate that in certain skin and subcutaneous cellular tissue infections, especially those caused by Group A b-Hemolytic Streptococcus, this delay in diagnosis may allow a simple infection to progress into NF.17
Guibal and collaborators utilize an animal model of streptococcal necrotizing fasciitis to study the effects of parenteral administration of nonsteroidal anti-inflammatories on the progression of the infection. The results suggest that the increasing severity of these infections, related to the use of anti-inflammatories, would be caused by a delay in diagnosis and treatment. This is due to the fact that its clinical effects lead to an apparent improvement of the condition, and not to reducing defenses.19
Up until the present time, the causal relation between necrotizing fasciitis and nonsteroidal anti-inflammatories cannot yet be established.
NF begins as an erythematous, sore and localized area, increasing hourly and daily and occurring in association with significant tissue edema. Local cyanosis and yellow or dark-reddish content blister formations occur thereafter. The area involved quickly becomes demarcated and circled by an erythematous border and covered over by necrotic tissue. At this time, anesthesia of the skin covering over the lesion develops. This is due to the destruction of the underlying subcutaneous tissue and thrombosis of the nutrient vessels, which causes necrosis of the nervous fibers.
Edema may be commonly observed prior to the appearance of other cutaneous signs. The very intense and disproportional pain is an important indication of NF, even after treatment begins.1
Necrosis of the fascia is typically more extensive than what the clinical aspect suggests. With affliction of the deepest tissue layers, extensive necrosis crust formation may occur.
If not treated, it is possible to have secondary involvement of the muscular layer, resulting in myositis or myonecrosis.
In the initial phase, it is difficult to distinguish NF from cellulitis.3
As for the most common primary infection site, the lower limbs represent roughly 50% of cases, followed by the upper limbs (29%), trunk (9%), perienal region (8%) and face (1%).2
Despite the fact that NF affects patients of any age group, there is a significant increase of incidence among the elderly (over 65 years of age), and with patients having at least one basic illness. However, various reports in the literature emphasize the occurrence of severe streptococcal infections and NF among previously healthy young adults. The affliction of children is less frequent, with roughly half of the cases occurring in patients with chicken pox.
There is no predilection with respect to sex.
The histopathology of NF demonstrates superficial necrosis of the fascia, polymorphonuclear infiltrate and reticular edema of the dermis, subcutaneous fat and superficial edema.1,2 Majeski carried out a freeze biopsy on a series of 43 patients who showed an inflammatory process. In 20 of them necrotizing fasciitis was confirmed. It was quickly and adequately treated without any deaths occurring. There was no case of infectious gangrene in the group in which the biopsy failed to reveal any evidence of NF. The author concluded the biopsy to be a complementary and useful method to establish the diagnosis of these infections in an early and precise way.23
The freeze biopsy, carried out prior to surgery, may be very useful for the diagnosis. It may reveal a soft infiltrate of polymorphonuclears with focal necrosis and formation of microabscesses on the fascia and subcutaneous tissue (Figure 5).3
By contrast, other authors consider quick progression, severity of the infection and isolation of Group A Streptococcus to be more important than the histopathologic findings of a necrotic area.24
Prior to the emergence of computerized tomography (CT), simple X-rays were utilized to confirm the presence of gas in the subcutaneum as evidence of NF (Figure 4). Nevertheless, as the gas was confined more superficially, it was rarely demonstrated by this test.
By contrast, CT provides excellent visualization of the presence and extension of abnormal gaz, in addition to evidencing necrosis with asymmetrical thickening of the fascia.
Walshaw and Deans revised the tomographies of 20 NF patients, and 11 (55%) of them showed subcutaneous gas. The authors suggest that the nine patients who did not show subcutaneous gas by CT represent cases of infection by microorganisms that are not productive of gas. Or these are cases in which early treatment prevents an accumulation of enough gas to be visualized.25
It is useful to recall that the presence of gas does not necessarily indicate infection by Clostridium, given that Escherichia coli, Peptostreptococcus and Bacteroides may produce gas under appropriate conditions.
CT may also help in the diagnostic differential for evidence of muscular involvement that suggests myonecrosis and other non NF conditions in which such involvement is late-onset or secondary.1
Magnetic resonance (MR), by the lack of accentuation of the gadolinium contrast in T1-weighted images, may provide an early diagnosis of NF, demonstrate the need for surgery and determine the extension of involvement, thereby facilitating the surgical procedure.26 It is a good technique for revealing the depth of infection and presence of necrosis.
Infections of the soft tissue parts, including cellulitis, myosites and fasciitis, are better evaluated by CT and MR due to excellent anatomic resolution and tissue contrast.27
DIAGNOSTIC AND DIFFERENTIAL DIAGNOSIS
In its early stages, it is difficult to distinguish NF from cellulitis. Several studies indicate that NF frequently begins with cellulitis and blisters. Moreover, NF and hemorrhaging blisters and cellulitis share many other common factors. Both conditions tend to be painful, with a potential to quickly evolve into necrosis and gangrene. They have the same predisposing factors and may have the same etiologic agents (Streptococcus pyogenes). Like NF, the hemocultures in hemorrhaging blisters and cellulitis are positive in more than 60% of cases. By contrast, they are invariably negative in typical cellulites.7
Diagnostic indexes for NF include inelastic edema, cyanosis, paleness and cutaneous hypoesthesia, crepitation, muscular weakness, fetid odor of exudates, absence of lymphangitis, rapid infection progression and lack of response to conventional antibiotherapy.
Systemic manifestations of sepsis are usually present, including changes in mental state, tachycardia, tachypnea, leukocytosis (>12000 mm3), fever (38.9-40.5oC), metabolic acidosis and hypocalcemia.3
The relatively benign appearance can be misleading and often results in delaying a diagnosis and an increase in morbidity and/or mortality. Early diagnosis is difficult and uncertain.
In the clinical history, one must be attentive to the predisposing factors present in most cases (71%). Report of previous trauma may occur in most lesions (skin lesions 47% and closed trauma 27%).2
Bacteriological tests (direct and cultures) from the wound exudate, blister fluid, excised tissue, aspired material from the subcutaneum and blood, are essential for an appropriate diagnosis.
Radiological exams may also be useful to establishment the diagnosis, aiding in the differential diagnosis, providing earlier surgical intervention and facilitating the surgical procedure.
The definitive diagnosis is effected during surgical exploration, resulting from the presence of necrosis of the fascia.
A polymerase chain reaction (PCR) is only used to detect streptococcal pyrogen exotoxins in the tissue.
Approximately half of NF patients show streptococcal toxic shock syndrome. The latter is an acute condition, fulminating with shock, thrombocytopenia, disseminated intravascular coagulation and/or multiple organ failure.2 Characteristically, the infection begins with severe local pain and nonspecific influenza-like symptoms.4
Some authors suggest that the term streptococcal toxic shock-like syndrome (STSLS) be used since the analogy with staphylococcal toxic shock syndrome is inadequate. The latter is caused by a production of toxins usually from a localized infection, is noninvasive and nonbacteremic. In STSLS, the infection is usually bacteremic and invasive, but not clearly caused by a pure toxin. Other virulent factors may be involved, such as M-protein, capsular polysaccharides and other extracellular enzymes.4
Laboratory findings include a reduction in white blood cell count with a predominance of immature granulocytes. Thrombocytopenia, hypocalcemia and hypoalbuminemia are also frequently observed. There may be an increase of seric creatinine and creatinine kinase.28
It is a rapidly progressing process, killing 30 to 60% of patients in the space of 72 to 96 hours.9
Other potential complications are acute renal insufficiency, coagulopathy, hepatic alterations and adult respiratory distress syndrome.
NECROTIZING FASCIITIS IN CHILDREN
NF is predominantly an adult's disease. In children, it is relatively rare and runs a fulminating course with a high mortality rate.
In newborns, most cases are attributed to secondary umbilical infection, balanitis, mammytis, post-operative complications and fetal monitoring.29
The diagnosis of NF may be considered through the presence of soft tissue infection with signs of toxicity and intense local edema, even with absence of fever and alteration in leukocyte count.30 The appearance of peau d'orange is quite characteristic.29,30 The flora is polymicrobian in most cases. Gram staining is not very useful as its result might be negative or demonstrate only one of the various microorganisms present.30
Chicken pox is often cited in the literature as a predisposing factor for NF in children. In such cases, NF is caused by secondary lesion infection by Group A Streptococcus and Staphylococcus. Surgery is recommended immediately for children with chickenpox showing symptoms of fever, tachycardia and leukocytosis in association with an erythematous lesion, induration and pain lasting two or three days after the onset of the viral infection. It should be pointed out that in spite of the risk of unnecessary surgery, the high-level of morbidity and mortality associated with a delay in surgical treatment justifies an early surgical exploration.31
It is also appropriate to underscore that the recent case/control study demonstrated that the use of ibuprophen increases the risk of complicated cellulitis in children with chickenpox.
Successful treatment involves early diagnosis, radical surgical debridement of the entire necrotic tissue, broad-spectrum parenteral antibiotherapy and general and aggressive patient support measures.22
The two most common flaws in the management of these cases are a delay in diagnosis and inadequate surgical debridement. Carrying out only an incision and drainage is an inadequate surgical strategy for these infections.32
Immediate surgical debridement (a few hours after beginning antibiotherapy) is indispensable if the erythema does not regress. Longitudinal incisions then have to be extended into the deep fascia and beyond the necrotic area. Various debridements often become necessary, and skin grafting is virtually always necessary.3
The general support measures are significant. Initial resuscitation includes control of hypotension and organ dysfunctioning resulting from severe sepsis. One must attend to preventing complications that may occur in association with prolonged, intensive treatment, including nutritional support and thromboembolic diseases.
Isolated antibiotherapy is not effective due to drug concentration involvement at the infection site, aggrieved by the necrosis and venous thrombosis.
Penicillin is the antibiotic of choice for treatment of streptococcal infections and has a broad spectrum of action: enterobacterias, streptococci, enterococci and anaerobics, including Bacteroides supp. Still, the clindamycin may be theoretically superior.4 In animal experiments, it has led to a drop in mortality in comparison with the Penicillin treatment. A possible mechanism would be the effect of clindamycin on the proteic synthesis, which may reduce superantigen production.8
Frequently, these two drugs are used jointly for treating severe infections for Streptococcus pyogenes. Studies in vitro suggest there to be no antagonism in the use of these two drugs. Nevertheless, there is no increased bacterial effect in relation to using either of them alone.
The retrospective study of children suggests that the clindamycin in combination with beta-lactamic drugs and surgery when indicated is the most effective treatment for invasive infections by S. Pyogenes.
The recommended clindamycin dose varies from two to four grams daily, begun at the earliest possible moment. As for Penicillin, use of Penicillin G is recommended in a dose of three to four million units every four hours.
When one suspects mixed infections or infection by anaerobics, an aminoglycoside is added to clindamycin or metronidazole.3 If in addition one suspects polymicrobial flora, monotherapy may be used, including imipenem/cilastatin or ticarcillin/clavulanate or piperacillin/tazobactam.
In patients allergic to Penicillin and at high risk of developing nephrotoxicity with aminoglycosides, therapy combined with third-generation antipseudomonal cephalosporin, with ceftazidime, in association with metronidazole or clindamycin, may be similarly effective.13
Pathogeny-based agents that limit cytokine production have been used with the objective of reducing tissue destruction. These include high doses of endovenous corticoids, gammaglobuline and antibodies against the TNF-alpha being investigated.
Kerdel emphasizes that adding systemic corticoids to antibiotherapy produces quick improvement, possibly occurring within five to seven days. The author reports a case in which endovenous methylprednisolone was used in a 100 mg dose every eight hours, and obtained very favorable results.8
The use of endovenous immunoglobulins has demonstrated a significant reduction of mortality in NF and STSLS. The most probable mechanism is neutralization of superantigens. The administering of gammaglobulin is suggested when the STSLS diagnosis is seriously considered; for example, hypotense patients with cellulitis of an unknown origin, patients with type II NF and toxemic patients with culture from any site testing positive for group A streptococcus, must receive endovenous gammaglobulin.4
Another therapy used is hyperbaric oxygen. There are two reasons for its use: polymorphism of bacterial flora with a predominance of anaerobics and tissue necrosis due to extensive microvascular obstruction within the infected area. Clark and Moon believe that studies in vitro and meta-analyses of clinical cases support the use of this therapy in spite of there not being randomized and controlled studies proving the effectiveness of the hyperbaric oxygen used in severe infections of the soft tissues.36 Mathieu asserts that the association with hyperbaric oxygenotherapy with antibiotherapy and surgery is based on consistent physiological findings, such as the ones found in animal studies. The use of hyperbaric oxygen for treating NF remains controversial owing more to the difficulty of making hyperbaric equipment available, and thereby allowing a patient in critical state to be managed, than from any doubts related to its real effectiveness.
At the present time, amputation is only performed exceptionally, namely when the afflicted limb has already become absolutely unviable.
The prognosis of NF depends on age, co-morbidities and severity of the septic syndrome.
The strongest predictor of mortality associated with NF is age. For patients under the age of 35, the mortality rate is significantly lower (0%) than when compared to mortality in patients over 70 years of age (65%). It is possible that instituting less aggressive treatment in elderly patients may have contributed to increasing the mortality indexes.2
Other significantly associated factors with increased risk of mortality are STSLS, hypotension with no other STSLS remnants and bacteremia. However, the latter may only be detected in a period varying from 24 to 48 hours after first appearing, which is of little use as an acceptable clinical marker.2
Mortality may reach 100% of surgically non-treated cases and when there is myositis.2,7
A few therapeutic modalities have been associated with improving the prognosis. Administering clindamycin, alone or in combination with Penicillin, has been associated with a drop in mortality when compared to other antibiotics.2
Despite better know-how and advances in treatment, NF continues to have mortality rates varying from 35 to 40%. Prior to 1980, young and healthy patients with isolated involvement of an extremity showed lower than 5 % mortality, while in those over 50 years of age or with trunk or perineal involvement mortality exceeded 60%. Mortality is also high in patients with chronic diseases, like diabetes mellitus or cardiovascular diseases. Since 1990, the global mortality rate has been roughly 30 %.1,3
Early diagnosis, and rapid and aggressive surgical intervention are capital to reducing morbidity and mortality. In cases diagnosed and treated within four days immediately after the onset of symptoms, the mortality rate drops to 12 %.3
Lille and col. recommend soliciting a surgeon's opinion in order to consider an early surgical exploration as soon as the diagnosis of NF is suspected. A delay in surgical intervention may bring on adverse consequences, either medical or legal.37
Treatment must be initiated at the earliest possible moment given that a few hours delay may be critical.4
Yet to reach the objective of reducing the infection's high morbidity and mortality indexes, it is necessary to observe various factors. What must be given utmost attention are cases of cellulitis. All such cases may be subject to surgery, especially blister and hemorrhagic cellulites. And this applies to patients with any one of the NF risk factors, whether by the most rigorous observation of the initial response to conventionally instituted antibiotherapy or by avoiding early release from hospital.
Even though some cases may show apparent improvement of It is necessary to attend to cases though they show apparent improvement of local signs and symptoms, the patient kept complaining of intense pain. As mentioned previously, once the diagnosis is reached, a surgeon's opinion must be solicited. Risk of an unnecessary surgical operation is supplanted by potential clinical and legal complications. Antibiotherapy must be implemented as soon as possible, bearing in mind the following items in order of importance: surgical debridement is first, with a preference for clindamycin use, which various papers have shown to be superior to Penicillin. When a mixed flora is suspected, the spectrum must be increased to include anaerobics in association with third-generation cephalosporin and metronidazole or other drugs like imipenem monotherapy. When complications such as shock set in, the patient must be treated preferentially in an intensive therapy unit with cardiac monitoring and adequate hydroelectrolytic control (fluid replacement), in addition to nutritional and respiratory support if and when necessary.
NF is a destructive bacterial infection of the subcutaneous tissue and superficial fascia which progresses rapidly. It is associated with high indexes of morbidity and mortality if not treated early. Hence the dermatologist must be attentive to the existence of this pathology, whose main diagnostic differential is cellulitis. Therefore, in the presence of a clinical condition compatible with cellulitis with partial response to antibiotherapy, especially if accompanied by pain and hemorrhagic blisters, a diagnosis of NF must be considered. This should allow an early therapeutic approach that can reduce its high morbidity and mortality indexes. q
1. Fink S, Chaudhuri TK, Davis HH. Necrotizing fasciitis and malpractice claims. South Med J 1999; 92(8):770-4. [ Links ]
2. Kaul R et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Am J Med 1997; 103:18-24. [ Links ]
3. Morantes MC, Lipsky BA. "Flesh-eating bacteria": return of an old nemesis. Internacional Journal of Dermatology 1995; 34(7)461-63. [ Links ]
4. Feingold DS, Weinberg AN. Group A streptococcal infections. An old adversary reemerging with new tricks?. Arch Dermatol 1996; 132:67-70. [ Links ]
5. Baskin LS, Carol PR, Catholic EVE et al. Necrotizing soft tissue infections of the perineum and genitalia: bacteriology, treatment, and risk assessment. Br J Urol 1990; 65:524-29. [ Links ]
6. Martin PR, Hoiby EA. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 1990; 22:421-29. [ Links ]
7. Gardam MA, Low DE, Saginur R, Miller MA. Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults. Arch Intern Med 1998; 158(15):1704-8. [ Links ]
8. Kerdel F. Necrotizing fasciitis: early recognition reduces morbidity/mortality. Dermatology Times 1998; 6-9. [ Links ]
9. Norrby SR, Norrby-Teglund A. Infections due to group A streptococcus: new concepts and potencial treatment strategies. Ann Acad Med Singapore 1997; 26(5):691-3. [ Links ]
10. Stevens DL. Streptococcal toxic schock syndrome associated with necrotizing fasciitis. Annu Rev Med 2000; 51:271-88. [ Links ]
11. Meltzer-DL, Kabongo-M. Necrotizing fasciitis: a diagnostic challenge. Am Fam Physician 1997; 56(1):145-9. [ Links ]
12. Jarret P, Rademaker M, Duffill M. The clinical spectrum of necrotizing fasciitis. A review of 15 cases. Aust N Z J Med 1997; 27(1):29-34. [ Links ]
13. Marcus JR, Hussong WJ, Gonzales C, Dumaniam GA. Risck factors in necrotizing fasciitis: a case involving Cryptococcus neoformans. Ann Plast Surg 1998; 40(1):80-3. [ Links ]
14. Hill MK, Sanders CV. Infections in critical care II. Critical Care Clinics 1998; 14(2):251-62. [ Links ]
15. Gonzales MH. Necrotizing fasciitis and gangrene of the upper extremity. Hand Clin 1998; 14(4):635-45. [ Links ]
16. Bilton BD et al. Agressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg 1998; 64(5):397-400. [ Links ]
17. Smith RJ, Berk SL. Necrotizing fasciitis and non-steroidal anti-inflamatory drugs. South Med J 1991; 86:785-87. [ Links ]
18. Holder EP, Moore PT, Browne BA. Nonsteroidal anti-inflammatory drugs and necrotizing fasciitis. An update. Drugs Saf 1997; 17(6):369-73. [ Links ]
19. Guibal F, Muffat-Joly M, Terris B, Garry L, Morel P, Carbon C. Effects of diclofenac on experimental streptococcal necrotizing fasciitis in rabbit. Arch Dermatol Res 1998; 290(11):628-33. [ Links ]
20. Stevens DL, Tanner MH, Winship I et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin. NEJM 1989; 321:1-7. [ Links ]
21. Forni al, Kaplan EL, Shlievert PM, Roberts RB. Clinical and microbiological characteristics of severe group A streptococcal infections and streptococcal toxic shock syndrome. Clin Infect Dis 1995; 21:333-40. [ Links ]
22. Chelsom I, J Halstensen A, Haga T, Hoiby EA. Necrotizing fasciitis due to group A streptococci in Western Norway: incidence and clinical features. Lancet 1994; 344:1111-1115. [ Links ]
23. Majeski J, Majeski E. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J 1997; 90(11):1065-8. [ Links ]
24. Ciccone G, Bonvicini R, Zanola S, Bombonato M, Ceraminiello A. Necrotizing fasciitis. A diagnostic and therapeutic challenge. Minerva Chir 1999; 54(11):819-23. [ Links ]
25. Walshaw CF, Deans H. CT findings in necrotizing fasciitis- a report of four cases. Clin Radiol 1996; 51:429-32. [ Links ]
26. Brothers TE and col. Magnetic resonance: imaging differentiates between necrotizing and non-necrotizing fasciitis of the low extremity. J Am Coll Surg 1998; 187(4):416-21. [ Links ]
27. Ma LD, Frassica FJ, Bluemke DA, Fishman EK. CT and MRI evaluation of musculoskeletal infection. Crit Ver Diagn Imaging 1997; 38(6):535-68. [ Links ]
28. Michael EP. Group A beta-hemolytic streptococcal infections. Pediatrics in Review 1998; 19(9):291-32. [ Links ]
29. Hsiech WS, Yang PH, Chao HC, Lai JY. Neonatal necrotizing fsciitis: a report of three cases and review of the literature. Pediatrics 1999; 103(4):e53. [ Links ]
30. Moss RL, Musemeche CA, Koloske AM. Necrotizing fasciitis in children: prompt recognition and aggressive therapy improve survival. J Pediatr Surg 1996; 31(8):1142-6. [ Links ]
31. Waldhausen JH, Holterman MJ, Sawin RS. Surgical implications of necrotizing fasciitis in children with chickenpox. J Pediatr Surg 1996; 31(8):1138-41. [ Links ]
32. Urschel JD. Necrotizing soft tissue infections. Postgrad Med J 1999; 75(889):645-9. [ Links ]
33. Stevens DL, Madaras-Kelly KJ, Richards DM. In vitro antimicrobial effects of various combinations of penicillin and clindamycin against four strains of Streptococcus pyogenes. Antimicrob Agents Chemother 1998; 42(5):1266-8. [ Links ]
34. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J 1999; 18(12):1096-100. [ Links ]
35. Cawley MJ, Briggs M, Haith LR Jr, Reilly KJ, Guilday RE, Braxton GR, Patton ML. Intravenous imunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review. Pharmacotherapy 1999; 19(9):1094-8. [ Links ]
36. Clark LA, Moon RE. Hiperbaric oxygen in the treatment of life-threatening soft-tissue infections. Respir Care Clin N Am 1999; 5(2):203-19. [ Links ]
37. Lille ST, Sato TT, Engrav LH et al: Necrotizing soft tissue infections: obstacles in diagnosis. J Am Coll Surg 1996; 182:7-11. [ Links ]
Izelda Maria Carvalho Costa
SHIS QI 17 Conjunto 08 Casa 02
71645- 080 Brasília DF
Tel.: (61) 364-1702
in April, 29th of 2002
Approved by the Consultive Council and accepted for publication in March, 18th of 2003
* Work done at "Hospital Universitário de Brasília".